Forest Laboratories Inc - Securities Registration: Employee Benefit Plan
August 14 2007 - 6:01AM
Edgar (US Regulatory)
Registration
No. 333-_______
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_________________
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
FOREST LABORATORIES, INC.
(Exact Name of Registrant as
Specified in Its Charter)
Delaware
|
(State of Other Jurisdiction of
Incorporation or Organization)
11-1798614
|
(I.R.S. Employer Identification
No.)
909 Third Avenue, New York, New
York 10022
|
(Address of Principal Executive
Offices) (Zip
Code)
2007 EQUITY INCENTIVE
PLAN
|
(Full Title of the
Plan)
Herschel S. Weinstein,
VP-General Counsel,
Forest Laboratories, Inc., 909 Third Avenue, New York, New York
10022
|
(Name and Address of Agent For
Service)
(212) 421-7850
|
Telephone Number, Including Area
Code, of Agent For Service.
|
CALCULATION OF REGISTRATION
FEE
|
Title of
Each Class of
Securities To
Be Registered
|
Amount
To Be
Registered(1)
|
Proposed
Maximum
Offering
Price Per
Share(2)
|
Proposed
Maximum
Aggregate
Offering
Price(2)
|
Amount of
Registration
Fee(3)
|
Common Stock
|
9,000,000 shares
|
$36.99
|
$322,910,000
|
$10,220.34
|
Common Stock
|
4,950,000 shares
|
N/A
|
N/A
|
N/A
|
(1) This registration statement (the
"Registration Statement") registers the offer and sale of up to
13,950,000 shares of Common Stock of Forest Laboratories, Inc., a
Delaware corporation (the "Company"), under the 2007 Equity
Incentive Plan (the "2007 Plan"). In addition, pursuant to Rule
416(c) under the Securities Act of 1933, this Registration
Statement also covers an indeterminate amount of interests to be
offered or sold pursuant to the employee benefit plan described
herein. The shares being registered consist of 9,000,000 shares
being newly registered and, pursuant to Instruction E to Form S-8
and interpretations of the Staff of the SEC’s Division of
Corporation Finance, 4,950,000 shares previously registered on
three registration statements on Form S-8 (3,148,726 shares from
the registration statement Registration No. 333-118969 filed
September 14, 2004, 1,784,879 shares from the registration
statement Registration No. 333-48656 filed October 26, 2000 and
16,395 shares from the registration statement Registration No.
333-65715 filed October 15, 1998. See "Explanatory Statement."
Pursuant to Rule 416(a), the number of shares being registered
shall be adjusted to include any additional shares which may become
issuable as a result of stock splits, stock dividends or similar
transactions in accordance with the anti-dilution provisions of the
2007 Plan.
(2) Estimated solely for the purpose of
calculating the registration fee. Pursuant to Rule 457(h)(1) under
the Securities Act of 1933, the proposed maximum price per share,
the proposed maximum aggregate offering price and the amount of
registration fee have been computed on the basis of the average of
the high and low prices of the Common Stock reported on the New
York Stock Exchange on August 9, 2007.
(3) Calculated pursuant to Section 6(b) of
the Securities Act of 1933, as amended, as follows: $30.70 per
$1 million of proposed maximum aggregate offering price. The
registration fee for the 4,950,000 shares was previously paid in
connection with the filing of the registration statements on Form
S-8 as described in footnote one above.
EXPLANATORY STATEMENT
On August 13, 2007, the Company’s stockholders approved
the Company’s 2007 Equity Incentive Plan (the "2007 Plan").
Prior to adoption of the 2007 Plan, the Company maintained three
option plans, the 2004 Stock Option Plan, the 2000 Stock Option
Plan and the 1998 Stock Option Plan (the "Prior Plans"). The shares
available for issuance upon the exercise of options granted under
each Prior Plan were registered on a Form S-8. Following adoption
of the 2007 Plan, no additional options will be granted under the
Company’s Prior Plans, and shares that were issuable upon the
exercise of options which remained available for grant under the
Prior Plans immediately before such adoption will be available for
issuance in connection with awards to be granted under the 2007
Plan. Pursuant to Instruction E to Form S-8, 4,950,000 of the
unissued shares previously registered with respect to the Prior
Plans are being carried forward and deemed covered by this
Registration Statement on Form S-8 relating to the 2007 Plan.
PART II
INFORMATION REQUIRED IN THE REGISTRATION
STATEMENT
Item 3. Incorporation
of Documents by Reference.
The following documents
filed with the Securities and Exchange Commission (the "SEC") are
incorporated by reference into this Registration Statement:
(a) The Annual Report of Forest Laboratories, Inc. (the
"Company") for the fiscal year ended March 31, 2007 on Form 10-K
filed pursuant to Section 13(a) of the Securities Exchange Act
of 1934 (the "Exchange Act"), filed with the SEC on May 30,
2007.
(b) All other reports of the Company filed pursuant to
Section 13(a) or 15(d) of the Exchange Act since the end of
the fiscal year ended March 31, 2007.
(c) The description of the Company’s Common Stock
contained in the Registration Statement on Form 8-A filed with the
SEC on September 28, 1999.
All documents subsequently filed by the Company pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior
to the filing of a post-effective amendment which indicates that
all securities offered have been sold or which deregisters all
securities then unsold, shall be deemed to be incorporated by
reference into this Registration Statement and to be a part hereof
from the date of filing of such documents.
Item
4. Description
of Securities.
Not
Applicable.
Item 5.
Interests
of Named Experts and Counsel.
Not
Applicable.
Item 6.
Indemnification
of Directors and Officers.
Section 145
of the Delaware General Corporation Law (the "DGCL") provides that
a corporation may indemnify directors and officers as well as other
employees and individuals against expenses (including
attorneys’ fees), judgments, fines and amounts paid in
settlement in connection with specified actions, suits or
proceedings, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the
corporation -- a "derivative action"), if they acted in good faith
and in a manner they reasonably believed to be in or not opposed to
the best interests of the corporation and, with respect to any
criminal actions or proceedings, had no reasonable cause to believe
their conduct was unlawful. A similar standard is applicable in the
case of derivative actions, except that indemnification only
extends to expenses (including attorneys’ fees) actually and
reasonably incurred in connection with the defense or settlement of
such action, and the DGCL requires court approval before there can
be any indemnification where the person seeking indemnification has
been found liable to the corporation. The DGCL provides that it is
not exclusive of other indemnification that may be granted by a
corporation’s by-laws, disinterested director vote,
stockholder vote, agreement or otherwise. Additionally,
Section 102(b)(7) of the DGCL permits a provision in the
certificate of incorporation of each corporation organized
thereunder, such as the Company, eliminating or limiting, with
certain exceptions, the personal liability of a director to the
corporation or its stockholders for monetary damages for breach of
fiduciary duty as a director.
The
Company’s Charter and Bylaws provide for indemnification of
officers and directors for claims that arise in connection with
their performance of services as officers and directors to the
fullest extent permitted by the DGCL. The right to indemnification
includes the right to be paid by the Company for expenses incurred
in defending any such proceeding in advance of its final
disposition. The right to indemnification under the Company’s
by-laws and certificate of incorporation is not exclusive of any
other right that any person may have or may acquire under any
statute, agreement or otherwise.
The
Company carries directors’ and officers’ liability
insurance that covers certain liabilities and expenses of the
Company’s directors and officers.
Item 7.
Exemption
from Registration Claimed.
Not
Applicable.
Item 8.
Exhibits.
Exhibit No.
|
|
Exhibit
|
|
|
|
4.1
|
|
The Company's Certificate of Incorporation, as amended, defining
the rights of holders of the Company's Common Stock. (Incorporated
herein by reference to Exhibit 3a to the Current Report on Form 8-K
dated March 9, 1981 filed by Forest, from Registration Statement on
Form S-1 (Registration No. 2-97792) filed by Forest on May 16,
1985, from Forest's definitive proxy statement filed pursuant to
Regulation 14A with respect to Forest's 1987, 1988 and 1993 Annual
Meetings of Stockholders and from the Current Report on Form 8-K
dated March 15, 1988.)
|
|
|
|
4.2
|
|
The Company’s By-Laws, as amended defining the rights of
holders of the Company’s Common Stock. (Incorporated herein
by reference to Exhibit 3b to the Current Report on Form 8-K dated
October 11, 1994.)
|
|
|
|
4.3
|
|
The 2007 Equity Incentive Plan approved by Stockholders on
August 13, 2007. (Incorporated herein by reference to Exhibit B to
the Company’s Proxy Statement relating to its 2007 Annual
Meeting of Stockholders.)
|
|
|
|
4.4
|
|
Form of Director Restricted Stock Agreement under the 2007
Equity Incentive Plan.
|
|
|
|
5.1
|
|
Opinion of Dornbush Schaeffer Strongin & Venaglia, LLP as to
the legality of the securities issued under the 2007 Equity
Incentive Plan.
|
|
|
|
23.1
|
|
Consent of BDO Seidman, LLP, independent certified public
accountants to the Company.
|
|
|
|
23.2
|
|
Consent of Dornbush Schaeffer Strongin & Venaglia, LLP,
counsel to the Company (contained in Exhibit 5.1).
|
|
|
|
24.1
|
|
Power of Attorney (included on the signature pages of this
Registration Statement)
|
Item 9.
Undertakings.
(a) The
undersigned Company hereby undertakes:
(1) To
file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
(i) to
include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933, any material information with respect to
the plan of distribution not previously disclosed in the
Registration Statement or any material change to such information
in the Registration Statement;
(ii) to
reflect in the prospectus any facts or events arising after the
effective date of this Registration Statement (or the most recent
post-effective amendment hereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the Registration Statement;
(iii) to
include any material information with respect to the plan of
distribution not previously disclosed in this Registration
Statement or any material change to such information in this
Registration Statement;
provided, however,
that paragraphs
(a)(1)(i) and (a)(1)(ii) do not apply if the information required
to be included in a post-effective amendment by those paragraphs is
contained in periodic reports filed with or furnished to the
Commission by the Registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 that are
incorporated by reference in the Registration Statement.
(2)
That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering
thereof.
(3)
To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.
(b) The
undersigned Company hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each
filing of the Company's annual report pursuant to
Section 13(a) or Section 15(d) of the Securities Exchange
Act of 1934 (and, where applicable, each filing of an employee
benefit plan's annual report pursuant to Section 15(d) of the
Securities Exchange Act of 1934) that is incorporated by reference
in the registration statement shall be deemed to be a new
registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.
(c) Insofar
as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers, and controlling
persons of the Company pursuant to the foregoing provisions, or
otherwise, the Company has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against
public policy as expressed in the Act and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than payment by the Company of
expenses paid or incurred by a director, officer or controlling
person of the Company in the successful defense of any action,
suit, or proceeding) is asserted by such director, officer, or
controlling person in connection with the securities being
registered, the Company will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the
Act and will be governed by the final adjudication of such
issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Company certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8 and has duly
caused this Registration Statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of New York
and State of New York, on the 13
th
day of August
2007.
FOREST
LABORATORIES, INC.
By:
/s/ Howard Solomon
Howard
Solomon,
Chairman
of the Board,
Chief
Executive
Officer
and Director
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS,
that each person
whose signature appears below constitutes and appoints Howard
Solomon and Lawrence S. Olanoff, M.D., Ph.D., and each of them, his
or her true and lawful attorney-in-fact and agent, with full power
of substitution and resubstitution, for him or her and in his or
her name, place and stead, in any and all capacities, to sign any
and all amendments (including post-effective amendments) to this
Registration Statement and all documents relating thereto, and to
file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them,
full power and authority to do and perform each and every act and
thing requisite and necessary to be done in and about the premises,
as fully to all intents and purposes as each might or could do in
person, hereby ratifying and confirming all that said
attorneys-in-fact and agents or any of them or their substitutes
may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in
the capacities and on the dates indicated.
SIGNATURE
|
TITLE
|
DATE
|
|
|
|
PRINCIPAL EXECUTIVE OFFICER:
|
|
|
/s/ Howard
Solomon
Howard Solomon
|
Chairman of the Board,
Chief Executive
Officer and Director
|
August 13, 2007
|
|
|
|
|
|
|
|
|
|
PRINCIPAL FINANCIAL AND
ACCOUNTING OFFICER:
|
|
|
|
|
|
/s/ Francis I. Perier, Jr.
Francis I. Perier, Jr.
|
Senior Vice President-
Finance and Chief
Financial Officer
|
August 13, 2007
|
|
|
|
|
|
|
DIRECTORS:
|
|
|
|
|
|
/s/ Lawrence S. Olanoff, M.D., Ph.D.
Lawrence S. Olanoff, M.D., Ph.D.
|
President, Chief
Operating Officer
and Director
|
August 13, 2007
|
|
|
|
|
|
|
/s/ Nesli Basgoz, M.D.
Nesli Basgoz, M.D.
|
Director
|
August 13, 2007
|
|
|
|
|
|
|
/s/ William J. Candee
William J. Candee
|
Director
|
August 13, 2007
|
|
|
|
|
|
|
/s/ George S. Cohan
George S. Cohan
|
Director
|
August 13, 2007
|
|
|
|
|
|
|
/s/ Dan L. Goldwasser
Dan L. Goldwasser
|
Director
|
August 13, 2007
|
|
|
|
|
|
|
/s/ Kenneth E. Goodman
Kenneth E. Goodman
|
Director
|
August 13, 2007
|
|
|
|
|
|
|
/s/ Lester B. Salans, M.D.
Lester B. Salans, M.D.
|
Director
|
August 13, 2007
|
EXHIBIT INDEX
Exhibit Number
|
|
Exhibit
|
|
|
|
4.4
|
|
Form of Director Restricted Stock Agreement under the 2007
Equity Incentive Plan.
|
|
|
|
5.1
|
|
Opinion of Dornbush Schaeffer Strongin & Venaglia, LLP,
including consent of such counsel.
|
|
|
|
23.1
|
|
Consent of BDO Seidman, LLP.
|
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Aug 2023 to Aug 2024